ArticlePLOS digital health2026
The Medicine Quality Monitoring Globe: A public health intelligence system for collecting and curating reports of substandard and falsified medical products from publicly available Internet news media.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
The circulation of substandard and falsified (SF) medical products, including medicines, vaccines, and medical devices, continues to impact health of populations worldwide. Meanwhile, surveillance of SF products and data sharing are limited in most of the world, and incidents are rarely published in accessible databases. We describe here the Medicine Quality Monitoring Globe system (MQM Globe) for capturing, curating, characterising, and disseminating online media reports relating to SF products. The system consists of the curation environment and the Web application. Online reports are acquired from search engines, direct feeds, and targeted extraction, in five languages. They then pass a series of automated content characterisation steps to filter and label them by relevance, location, and product. Reports are then reviewed by a trained curator staff, before being made available through a visualisation Web application. Over the study period from July 2018 through December 2024, we identified 11,000 relevant distinct SF incidents, across a broad range of geography, products, and categories. The automated relevance classifier exhibited precision of 37%, recall 90%, and F1-score 52%, for English-language content. The information captured by the MQM Globe is publicly available and can help inform public health authorities as situations emerge. It is the only publicly available repository of open source intelligence specifically on SF medical products. It can be used as an informational tool to trigger intelligence-led activities across law enforcement, customs and Medicine Regulatory Authorities.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.